Leah Bressler

Dr. Smith, a reproductive urologist at UCSF, educated us on the impact of cancer treatment on male fertility and the growing need for male oncofertility treatments as childhood cancer survival rates continues to increase. As has been a theme today, Dr. Smith reviewed how alkylating agents are...

Leah Bressler

Dr. Su, of UCSD, gave an eloquent and stimulating lecture reviewing medical considerations in adolescents undergoing controlled ovarian stimulation for fertility preservation. Mature oocyte and embryo cryopreservation are established fertility preservation methods associated with high success rates...

Allison Goetsch

Yesterday we announced our NEW Oncofertility Decision Tool Web Portal. This online portal serves as a one-stop-shop for health care providers in need of tools to facilitate fertility preservation conversations with their patients whose disease, or its treatment, threatens fertility. In addition to...

Oncofertility Consortium

By Cathryn Smeyers

This is the final installment in a two-part blog story featuring Oncofertility Consortium member, Gregory Dolin, MD, JD, focusing on his recent Oncofertility Virtual Grand Rounds presentation. To read the 1st blog, click here.

In his presentation, Dr. Dolin highlighted some of...

ltce

I just returned from the annual Oncofertility Consortium Conference and one of the ethical topics that came up was the possibility of disputes over frozen reproductive materials. Before undergoing life-saving cancer treatment, people may opt to freeze gametes, gonadal tissue, or embryos in order to...

ltce

A recent New York Times article shares the story of Debra Demidon, who developed severe ovarian hyperstimulation syndrome (OHSS) after undergoing IVF. This potentially life-threatening condition caused her to gain more than 30 pounds of fluid and have trouble breathing, and ultimately landed her in...

Pages